John Chisholm (engineer)

Last updated

Sir John Alexander Raymond Chisholm FREng CEng FIEE FRAeS FInstP [1] (born 27 August 1946) is a British engineer who was chairman of the Medical Research Council and QinetiQ. [2]

Chisholm was born in India of Scottish parents, Ruari Ian Lambert Chisholm and Pamela Harland Frank, and brought up in Calcutta. Mairi Chisholm was his great-aunt. [2] [3] He was educated at Worth School,[ citation needed ] and later attended Cambridge University, reading Mechanical Sciences on a scholarship from General Motors. After completing his studies, he worked at GM from 1968 as a graduate apprentice before joining BP's computer consultancy firm Scicon in 1969. He joined leading systems house CAP and founded a divisional company within that group called CAP Scientific Ltd in 1979 of which he was managing director. In 1988, CAP merged with SEMA-METRA, a French company and the merged group was called Sema Group allowing it to trade in Europe where "CAP" was already used by an historical link with CAP-Gemini. SEMA-METRA was cash rich whereas CAP Group had a very strong order book. This allowed balancing of the new group's portfolio. In practice some would regard the move as a reverse takeover due to the relative strength of the French component of the company. Chisholm was UK managing director of Sema Group plc.

In 1991, Chisholm was asked by the UK Ministry of Defence to organize a number of their research organisations into a single entity, which eventually became the Defence Evaluation and Research Agency (DERA) - the largest science and technology organisation in the UK. In July 2001, three quarters of DERA was spun off to form a new private company called QinetiQ. In late 2005 Chisholm became Executive Chairman of QinetiQ, being replaced as CEO by Graham Love. According to The Sunday Times his annual pay was £467,000 in 2004. His £129,000 investment in the company was later worth £23m (a 17,829.5% return on investment, almost 180 times the initial value of the investment, which led to suggestions the company was undervalued). [4] In 2008, the chairman of the House of Commons Public Accounts Committee accused Chisholm of "profiteering at the expense of the taxpayer". In response, Chisholm stated that the criticisms were "grossly unfair", and that "the reshaping of QinetiQ had been the greatest achievement of my working life". At that time, his stake was worth just over £21m. [5]

Chisholm has been President of the Electrical Engineering Association. He was President and Trustee of the Institution of Engineering & Technology (formerly Institution of Electrical Engineers) (2005–2006). He was knighted in the 1999 New Year Honours. [6] John is a Fellow of the Royal Academy of Engineering, the Royal Aeronautical Society, the Institute of Physics. He holds honorary Doctor of Engineering degrees from the Universities of Bath, Southampton and Brunel. He was a founding member of the British Government's Technology Foresight programme.

Appointed Chairman of the Medical Research Council by the Government, a position he took up in October 2006, he succeeded Sir Anthony Cleaver who had been in the post since 1998. Cleaver welcomed Chisholm's appointment stating him as a strong advocate for research. "Sir John's passion in promoting the value of research will be invaluable to the Medical Research Council as we enter a further period of change." [7]

In 2007 the House of Commons Select Committee on Science and Technology, after describing him as vague and evasive in answering questions, said "we have serious reservations as to whether Sir John is the right person to guide the MRC Executive through the coming period of change". Despite his lack of medical qualifications, the Government refuted this statement saying that "Sir John has a first class background in business and has all the qualities and the perspective needed to chair the MRC Council successfully through this period of change...". [8]

The Government also stated in response to the report by House of Commons Select Committee on Science and Technology that "The MRC is entering a period of change as the Centre's role in developing research evidence to support decision making in policy and practice was highlighted in the Cooksey report recommendations are put into effect. The new Chairman's career record—in particular his experience in managing change and translating research into marketable products—indicates that he should be well suited to a non-executive Chairman's role at this stage in the MRC's evolution." [9]

Chisholm was appointed Chairman of NESTA (National Endowment for Science Technology and the Arts) on the first of November 2009.

In 2010, Chisholm retired from the QinetiQ board, being replaced as Chairman by Mark Elliott. [10] He retired as MRC Chairman in September 2012, replaced by Donald Brydon.

Notes

  1. "List of Fellows". Archived from the original on 8 June 2016. Retrieved 14 October 2014.
  2. 1 2 Mosley, Charles, ed. (2003). Burke's Peerage, Baronetage & Knighthood (107 ed.). Burke's Peerage & Gentry. pp. 780–781. ISBN   0-9711966-2-1.
  3. "Brunel University honorary doctorate citation 2006". Archived from the original on 4 March 2016.
  4. "Qinetiq deal 'cost UK taxpayers'". BBC News. 22 November 2007. Retrieved 22 November 2007.
  5. Times Online feb 8 2009
  6. UK list: "No. 55354". The London Gazette (1st supplement). 31 December 1998. p. 1.
  7. MRC News Release 8 May 2006 Archived 15 June 2011 at the Wayback Machine
  8. The Committee Office, House of Commons. "House of Commons - Science and Technology - Sixth Special Report". Publications.parliament.uk. Retrieved 9 June 2012.
  9. The Committee Office, House of Commons. "House of Commons - Science and Technology - Eighth Report". Publications.parliament.uk. Retrieved 9 June 2012.
  10. "QinetiQ board change announcement".

Related Research Articles

<span class="mw-page-title-main">Brunel University London</span> University in Uxbridge, London

Brunel University London is a public research university located in the Uxbridge area of London, England. It was founded in 1966 and named after Isambard Kingdom Brunel, a Victorian engineer and pioneer of the Industrial Revolution. In June 1966, Brunel College of Advanced Technology was awarded a royal charter and became Brunel University; in 2014 the university formally adopted the name Brunel University London (BUL). The university is considered a British plate glass university. In October 2024, Brunel will join the federal University of London to become the federation's 18th member.

Sir Richard Brook Sykes is a British microbiologist, the chair of the Royal Institution, the UK Stem Cell Foundation, and the trustees at King Edward VII's Hospital, and chancellor of Brunel University. As of June 2021, he is chair of the UK's Vaccine Taskforce, where he is responsible for overseeing the delivery of the COVID-19 vaccination programme, including preparations for booster programmes and encouraging vaccine innovation in the UK.

<span class="mw-page-title-main">Porton Down</span> Military science park in Wiltshire, England

Porton Down is a science and defence technology campus in Wiltshire, England, just north-east of the village of Porton, near Salisbury. It is home to two British government facilities: a site of the Ministry of Defence's Defence Science and Technology Laboratory – known for over 100 years as one of the UK's most secretive and controversial military research facilities, occupying 7,000 acres (2,800 ha) – and a site of the UK Health Security Agency. Since 2018, part of the campus has housed Porton Science Park, which is owned and operated by Wiltshire Council and has private sector companies in the health, life science and defence and security sectors.

The Defence Evaluation and Research Agency (DERA) was a part of the UK Ministry of Defence (MoD) between 1995 and 2 July 2001. At the time it was the United Kingdom's largest science and technology organisation. It was regarded by its official history as 'a jewel in the crown' of both government and industry.

<span class="mw-page-title-main">Medical Research Council (United Kingdom)</span> National medical research agency

The Medical Research Council (MRC) is responsible for co-coordinating and funding medical research in the United Kingdom. It is part of United Kingdom Research and Innovation (UKRI), which came into operation 1 April 2018, and brings together the UK's seven research councils, Innovate UK and Research England. UK Research and Innovation is answerable to, although politically independent from, the Department for Business, Energy and Industrial Strategy.

QinetiQ is a multinational defence technology company headquartered in Farnborough, Hampshire. It operates primarily in the defence, security and critical national infrastructure markets and run testing and evaluation capabilities for air, land, sea and target systems.

<span class="mw-page-title-main">Gregory Winter</span> English biochemist (born 1951)

Sir Gregory Paul Winter is a Nobel Prize-winning English molecular biologist best known for his work on the therapeutic use of monoclonal antibodies. His research career has been based almost entirely at the MRC Laboratory of Molecular Biology and the MRC Centre for Protein Engineering, in Cambridge, England.

The Defence Research Agency (DRA) was an executive agency of the UK Ministry of Defence (MOD) from April 1991 until April 1995. At the time, the DRA was Britain's largest science and technology organisation. In April 1995, the DRA was combined with five other MOD establishments to form the Defence Evaluation and Research Agency.

<span class="mw-page-title-main">Colin Blakemore</span> British neurobiologist (1944–2022)

Sir Colin Blakemore,, Hon was a British neurobiologist, specialising in vision and the development of the brain. He was Yeung Kin Man Professor of Neuroscience and senior fellow of the Hong Kong Institute for Advanced Study at City University of Hong Kong. He was a distinguished senior fellow in the Institute of Philosophy, School of Advanced Study, University of London and Emeritus Professor of Neuroscience at the University of Oxford and a past Chief Executive of the British Medical Research Council (MRC). He was best known to the public as a communicator of science but also as the target of a long-running animal rights campaign. According to The Observer, he was both "one of the most powerful scientists in the UK" and "a hate figure for the animal rights movement".

The Engineering and Physical Sciences Research Council (EPSRC) is a British Research Council that provides government funding for grants to undertake research and postgraduate degrees in engineering and the physical sciences, mainly to universities in the United Kingdom. EPSRC research areas include mathematics, physics, chemistry, artificial intelligence and computer science, but exclude particle physics, nuclear physics, space science and astronomy. Since 2018 it has been part of UK Research and Innovation, which is funded through the Department for Business, Energy and Industrial Strategy.

Charles Thomas Elliott, , is a scientist in the fields of narrow gap semiconductor and infrared detector research.

Sir Michael John Howard Sterling is a British professor, and a former Vice-Chancellor of the Brunel University and the University of Birmingham.

Graham Love was the chief executive officer of the defence contractor, QinetiQ Group plc. He is a graduate of Cambridge University and a chartered accountant.

<span class="mw-page-title-main">CAP Scientific</span> Software company in United Kingdom

CAP Scientific Ltd was a British defence software company, and was part of CAP Group plc. In 1988, CAP Group merged with the French firm Sema-Metra SA in 1988 as Sema Group plc. In 1991 Sema Group put most of its defence operations into joint venture with British Aerospace called BAeSEMA, which British Aerospace bought out in 1998. Parts of the former CAP Scientific are now BAE Systems (Insyte).

<span class="mw-page-title-main">Parliamentary Office of Science and Technology</span>

The Parliamentary Office of Science and Technology (POST) is the Parliament of the United Kingdom's in-house source of independent, balanced and accessible analysis of public policy issues related to science and technology. POST serves both Houses of Parliament.

Sir Gareth Gwyn Roberts was a Welsh physicist specialising in semiconductors and molecular electronics, who was influential in British science policy through his chairmanship of several academic bodies and his two reports on the future supply of scientists and how university research should be assessed. He was knighted in 1997 for his services to higher education.

<span class="mw-page-title-main">CAP Group</span> Software company in United Kingdom

CAP Group was a British software house. Computer Analysts and Programmers Ltd (CAP) was founded in May 1962 and grew to be one of the foremost IT companies in the UK before merging with French company Sema-Metra in 1988 to form Sema Group.

Sir Anthony Brian Cleaver HonFREng is a British engineer and executive. He started his career as a systems engineer with IBM UK Ltd in 1962. He was later Chairman of the United Kingdom Atomic Energy Authority and steered AEA Technology through its privatisation. He has also chaired the UK Nuclear Decommissioning Authority and the Medical Research Council.

Sir John Irving Bell is a Canadian-British immunologist and geneticist. From 2006 to 2011, he was President of the United Kingdom's Academy of Medical Sciences, and since 2002 he has held the Regius Chair of Medicine at the University of Oxford. He was since 2006 Chairman of the Office for Strategic Coordination of Health Research (OSCHR) but in 2020 became a normal member. Bell was selected to the Vaccine Taskforce sometime before 1 July 2020. Bell is also on the board of directors of the SOE quango Genomics England.

<span class="mw-page-title-main">Francis Crick Institute</span> Biomedical research centre in London

The Francis Crick Institute is a biomedical research centre in London, which was established in 2010 and opened in 2016. The institute is a partnership between Cancer Research UK, Imperial College London, King's College London (KCL), the Medical Research Council, University College London (UCL) and the Wellcome Trust. The institute has 1,500 staff, including 1,250 scientists, and an annual budget of over £100 million, making it the biggest single biomedical laboratory in Europe.

References